Indication
Graft-versus-host disease
Graft-versus-host disease is a systemic alloimmune complication occurring primarily after allogeneic hematopoietic stem cell transplantation, in which immunocompetent donor T lymphocytes recognize host histocompatibility antigens as foreign and mount an immune attack against recipient tissues. Read more about Graft-versus-host disease
3 drugs 2 manufacturers
Drugs that treat it
Common Graft-versus-host disease therapies.
RYONCIL (remestemcel-L-rknd)
JAKAFI XR (ruxolitinib phosphate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonGraft-versus-host disease is a systemic alloimmune complication occurring primarily after allogeneic hematopoietic stem cell transplantation, in which immunocompetent donor T lymphocytes recognize host histocompatibility antigens as foreign and mount an immune attack against recipient tissues.
The condition is broadly classified into acute and chronic forms based on clinical presentation and timing.
Acute manifestations characteristically involve maculopapular rash, secretory diarrhea, and cholestatic hepatitis, whereas chronic disease features widespread autoimmune-like inflammation and progressive tissue fibrosis affecting the skin, mouth, eyes, liver, lungs, and musculoskeletal system.
- nih.gov
Graft-versus-host disease is a systemic alloimmune complication occurring primarily after allogeneic hematopoietic stem cell transplantation, in which immunocompetent donor T lymphocytes recognize host histocompatibility antigens as foreign and mount an immune attack against recipient tissues
- nih.gov
Graft-versus-host disease is a systemic alloimmune complication occurring primarily after allogeneic hematopoietic stem cell transplantation, in which immunocompetent donor T lymphocytes recognize host histocompatibility antigens as foreign and mount an immune attack against recipient tissues
- nih.gov
The condition is broadly classified into acute and chronic forms based on clinical presentation and timing Acute manifestations characteristically involve maculopapular rash, secretory diarrhea, and cholestatic hepatitis, whereas chronic disease features widespread autoimmune-like inflammation and progressive tissue fibrosis affecting the skin, mouth, eyes, liver, lungs, and musculoskeletal system
- pfizer.com
The condition is broadly classified into acute and chronic forms based on clinical presentation and timing
- nih.gov
Acute manifestations characteristically involve maculopapular rash, secretory diarrhea, and cholestatic hepatitis, whereas chronic disease features widespread autoimmune-like inflammation and progressive tissue fibrosis affecting the skin, mouth, eyes, liver, lungs, and musculoskeletal system
- acibademinternational.com
Acute manifestations characteristically involve maculopapular rash, secretory diarrhea, and cholestatic hepatitis, whereas chronic disease features widespread autoimmune-like inflammation and progressive tissue fibrosis affecting the skin, mouth, eyes, liver, lungs, and musculoskeletal system
Personalize your experience
Follow Graft-versus-host disease and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.